Bruce Strober
Overview
Explore the profile of Bruce Strober including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
103
Citations
1933
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Armstrong A, Lebwohl M, Warren R, Sofen H, Morita A, Paul C, et al.
J Eur Acad Dermatol Venereol
. 2025 Mar;
PMID: 40045918
Background: Deucravacitinib, an oral, selective, allosteric tyrosine kinase 2 (TYK2) inhibitor, is approved in multiple countries for treatment of adults with moderate to severe plaque psoriasis who are candidates for...
2.
Langley R, Egeberg A, Gooderham M, Bissonnette R, Ringuet J, Kalia S, et al.
J Eur Acad Dermatol Venereol
. 2025 Feb;
PMID: 39985198
No abstract available.
3.
Warren R, Lebwohl M, Thaci D, Gooderham M, Pinter A, Paul C, et al.
Br J Dermatol
. 2025 Jan;
PMID: 39862230
Background: Overexpression of interleukin (IL)-17A and IL-17F significantly influences psoriasis pathology. Until recently, biologics targeting IL-17A alone, like secukinumab, were used to treat psoriasis. Bimekizumab is a monoclonal IgG1 antibody...
4.
Barker J, Casanova E, Choon S, Foley P, Fujita H, Gonzalez C, et al.
Br J Dermatol
. 2025 Jan;
PMID: 39844356
Background: Generalised pustular psoriasis (GPP) is a chronic, systemic, neutrophilic inflammatory disease. A previous Delphi panel established areas of consensus on GPP, although patient perspectives were not included, and aspects...
5.
Patel V, Park S, Zhong Y, Sima A, Zhuo J, Roberts-Toler C, et al.
Psoriasis (Auckl)
. 2024 Dec;
14:167-174.
PMID: 39624651
Purpose: This real-world study investigated the impact of patient-reported disease burden and health-related quality of life (HRQoL) on switching from systemic nonbiologic to biologic therapy in patients with plaque psoriasis....
6.
Armstrong A, Lebwohl M, Warren R, Sofen H, Imafuku S, Ohtsuki M, et al.
JAMA Dermatol
. 2024 Nov;
161(1):56-66.
PMID: 39602111
Importance: Safe and effective long-term treatments for moderate to severe plaque psoriasis are needed. Objective: To evaluate the long-term safety and efficacy of deucravacitinib through 3 years (week 148) in...
7.
Strober B, Zhong Y, Sima A, Beeghly A, Eckmann T, Balagula E, et al.
J Psoriasis Psoriatic Arthritis
. 2024 Nov;
:24755303241302070.
PMID: 39583219
Background: The International Psoriasis Council (IPC) updated the classification of psoriasis severity to guide clinical decision-making. According to IPC guidelines, patients are considered candidates for systemic therapy when body surface...
8.
Armstrong A, Soliman A, Gisondi P, Fang S, Patel M, Strober B
Dermatol Ther (Heidelb)
. 2024 Oct;
14(11):3071-3081.
PMID: 39453596
Introduction: Despite advancements in the treatment of psoriasis (PsO), there are few head-to-head studies assessing comparative effectiveness of the newest therapies approved to treat PsO. Our objective was to assess...
9.
Lebwohl M, Medeiros R, Mackey R, Valdecantos W, Brodovicz K, Lertratanakul A, et al.
J Psoriasis Psoriatic Arthritis
. 2024 Sep;
8(2):56-65.
PMID: 39296672
Background: Palmoplantar pustulosis (PPP) is a rare skin disease characterized by episodes of neutrophilic pustules on the palms of the hands and soles of the feet. Current treatments for PPP...
10.
Goldburg S, Chen R, Langholff W, Lafferty K, Gooderham M, de Jong E, et al.
J Psoriasis Psoriatic Arthritis
. 2024 Sep;
7(3):132-139.
PMID: 39296535
Patterns of psoriasis characteristics by sex are not fully understood. Evaluate patient characteristics by sex at enrollment in the Psoriasis Longitudinal Assessment and Registry (PSOLAR). Two PSOLAR cohorts were evaluated...